What is the recommended infusion rate of hypertonic sodium (hypertonic saline) 3% solution for severe symptomatic hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypertonic Sodium 3% Infusion Rate for Severe Symptomatic Hyponatremia

For severe symptomatic hyponatremia, 3% hypertonic saline should be administered with an initial goal to correct 6 mmol/L over 6 hours or until severe symptoms resolve, with a maximum correction of 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome. 1, 2

Initial Management Based on Symptom Severity

Severe Symptoms (seizures, coma, severe neurological symptoms)

  • Administer 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours or until severe symptoms resolve 1, 2
  • Initial infusion rate can be calculated as: body weight (kg) × desired rate of increase in sodium (mmol/L per hour) 3
  • After initial 6 mmol/L correction, limit to only 2 mmol/L in the following 18 hours 2
  • Discontinue 3% hypertonic saline once severe symptoms resolve 2
  • Monitor serum sodium every 2 hours during initial correction 1

Moderate to Mild Symptoms

  • For less severe symptoms, transition to fluid restriction of 1L/day after resolution of severe symptoms 1, 2
  • Consider oral sodium supplementation (NaCl 100 mEq orally three times daily) for mild symptoms 4
  • Monitor serum sodium every 4 hours after resolution of severe symptoms 2

Critical Safety Parameters

  • Total correction should not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 2, 4
  • Rapid correction (>1 mmol/L/h) should only be used for severely symptomatic and/or acute hyponatremia (≤48 hours) 2
  • For chronic hyponatremia (>48-72 hours), slower correction is safer after initial symptom control 2
  • Patients with advanced liver disease, alcoholism, malnutrition require even more cautious correction (4-6 mmol/L per day) 1, 4

Special Considerations

  • For cerebral salt wasting (CSW), treatment focuses on volume and sodium replacement with 3% hypertonic saline and fludrocortisone for severe symptoms 1
  • In subarachnoid hemorrhage patients at risk for vasospasm, avoid fluid restriction 1, 4
  • For patients with cirrhosis and severe hyponatremia, use even more cautious correction rates (4-6 mmol/L per day) 1
  • Watch for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction 1

Management After Initial Correction

  • After severe symptoms resolve, switch to protocols for mild symptoms or asymptomatic hyponatremia 2
  • Continue treatment until sodium reaches 131 mmol/L 2
  • Exception: Subarachnoid hemorrhage patients receive treatment even for sodium levels of 131-135 mmol/L 2

Risk of Overcorrection

  • Monitor for spontaneous water diuresis which can lead to overcorrection 5
  • If overcorrection occurs, consider relowering with electrolyte-free water or desmopressin 1, 6
  • The risk of overcorrection is higher in severely symptomatic patients 4

Recent Evidence

Recent guidelines emphasize that rapid intermittent administration of hypertonic saline is preferred for treatment of symptomatic hyponatremia, with bolus infusions of 100-150 ml of 3% saline rather than continuous infusion 5.

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Discontinuation of 3% Normal Saline in Severe Symptomatic Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oral Sodium Supplementation in Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

The treatment of hyponatremia.

Seminars in nephrology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.